Ryan Charles S.
SEC CIK 1624830 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Pres | 130.0K | $31.5K | — | 2 | 2024-08-20 | 2025-06-18 |
Most active insiders at QNCX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Benatti Luca | Dir | — | $173.5K |
| 2 | Hannah Brendan | COO, CCO, CBO | — | — |
| 3 | Thye Dirk | CEO, CMO, Dir | — | — |
Ryan Charles S. made no open-market trades at QNCX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-23 | 2025-06-18 | QNCX | Quince Therapeutics, Inc. | Ryan Charles S. | Pres | A - Grant | $1.20 | +7,548 | 130.0K | +6% | +$9,058 |
| 2024-08-22 | 2024-08-20 | QNCX | Quince Therapeutics, Inc. | Ryan Charles S. | Pres | P - Purchase | $0.65 | +48.4K | 122.5K | +65% | +$31.5K |
Purchase Sale Sale after option exercise All abbreviations